B cells as a therapeutic target for IFN-β in relapsing-remitting multiple sclerosis

Journal of Immunology

Volumn 186, Issue 7, 2011, Pages 4518-4526

  Ramgolam, Vinod S ^a   Sha, Yonggang ^a   Marcus, Karen L ^a   Choudhary, Neelima ^a   Troiani, Luigi ^a   Chopra, Manisha ^a   Markovic Plese, Silva ^a,b  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

B7 ANTIGEN; CD40 ANTIGEN; INTERFERON BETA SERINE; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 17; INTERLEUKIN 1BETA; INTERLEUKIN 23; INTERLEUKIN 27; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; ORPHAN NUCLEAR HORMONE RECEPTOR C; ORPHAN NUCLEAR RECEPTOR; UNCLASSIFIED DRUG;

ANTIGEN EXPRESSION; ARTICLE; B LYMPHOCYTE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; DOWN REGULATION; DRUG MECHANISM; DRUG TARGETING; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IN VITRO STUDY; IN VIVO STUDY; LYMPHOCYTE DIFFERENTIATION; MULTIPLE SCLEROSIS; PRIORITY JOURNAL; TH17 CELL;

ADJUVANTS, IMMUNOLOGIC; B-LYMPHOCYTE SUBSETS; CELLS, CULTURED; COCULTURE TECHNIQUES; DENDRITIC CELLS; DRUG DELIVERY SYSTEMS; HUMANS; INTERFERON-BETA; INTERLEUKIN-1BETA; INTERLEUKIN-23; LYMPHOCYTE CULTURE TEST, MIXED; MULTIPLE SCLEROSIS, RELAPSING-REMITTING;

EID: 79954997896     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1000271     Document Type: Article

References (39)

1. The IFNB Multiple Sclerosis Study Group. 1993. Interferon beta-1b is effective in relapsing-remitting multiple sclerosis. I. Clinical results of a multicenter, randomized, double-blind, placebo-controlled trial. Neurology 43: 655-661.
2. Comabella, M., J. Rio, C. Espejo, M. Ruiz de Villa, H. Al-Zayat, C. Nos, F. Deisenhammer, S. E. Baranzini, L. Nonell, C. Lopez, et al.. 2009. Changes in matrix metalloproteinases and their inhibitors during interferon-beta treatment in multiple sclerosis. Clin. Immunol. 130: 145-150.
3. Prinz, M., H. Schmidt, A. Mildner, K. P. Knobeloch, U. K. Hanisch, J. Raasch, D. Merkler, C. Detje, I. Gutcher, J. Mages, et al.. 2008. Distinct and nonredundant in vivo functions of IFNAR on myeloid cells limit autoimmunity in the central nervous system. Immunity 28: 675-686.
4. Durelli, L., L. Conti, M. Clerico, D. Boselli, G. Contessa, P. Ripellino, B. Ferrero, P. Eid, and F. Novelli. 2009. T-helper 17 cells expand in multiple sclerosis and are inhibited by interferon-beta. Ann. Neurol. 65: 499-509.
5. Matusevicius, D., P. Kivisäkk, B. He, N. Kostulas, V. Ozenci, S. Fredrikson, and H. Link. 1999. Interleukin-17 mRNA expression in blood and CSF mononuclear cells is augmented in multiple sclerosis. Mult. Scler. 5: 101-104. (Pubitemid 29186827)
6. Tzartos, J. S., M. A. Friese, M. J. Craner, J. Palace, J. Newcombe, M. M. Esiri, and L. Fugger. 2008. Interleukin-17 production in central nervous systeminfiltrating T cells and glial cells is associated with active disease in multiple sclerosis. Am. J. Pathol. 172: 146-155. (Pubitemid 351186376)
7. Lock, C., G. Hermans, R. Pedotti, A. Brendolan, E. Schadt, H. Garren, A. Langer-Gould, S. Strober, B. Cannella, J. Allard, et al.. 2002. Gene-microarray analysis of multiple sclerosis lesions yields new targets validated in autoimmune encephalomyelitis. Nat. Med. 8: 500-508. (Pubitemid 34546753)
8. Ramgolam, V. S., Y. Sha, J. Jin, X. Zhang, and S. Markovic-Plese. 2009. IFNbeta inhibits human Th17 cell differentiation. J. Immunol. 183: 5418-5427.
9. Antel, J., and A. Bar-Or. 2006. Roles of immunoglobulins and B cells in multiple sclerosis: from pathogenesis to treatment. J. Neuroimmunol. 180: 3-8. (Pubitemid 44692323)
10. Fillatreau, S., D. Gray, and S. M. Anderton. 2008. Not always the bad guys: B cells as regulators of autoimmune pathology. Nat. Rev. Immunol. 8: 391-397. (Pubitemid 351595221)
11. Prineas, J. W., and R. G. Wright. 1978. Macrophages, lymphocytes, and plasma cells in the perivascular compartment in chronic multiple sclerosis. Lab. Invest. 38: 409-421. (Pubitemid 8338235)
12. Hauser, S. L., E. Waubant, D. L. Arnold, T. Vollmer, J. Antel, R. J. Fox, A. Bar- Or, M. Panzara, N. Sarkar, S. Agarwal, et al.; HERMES Trial Group. 2008. B-cell depletion with rituximab in relapsing-remitting multiple sclerosis. N. Engl. J. Med. 358: 676-688. (Pubitemid 351240747)
13. Jiang, H., R. Milo, P. Swoveland, K. P. Johnson, H. Panitch, and S. Dhib-Jalbut. 1995. Interferon beta-1b reduces interferon gamma-induced antigen-presenting capacity of human glial and B cells. J. Neuroimmunol. 61: 17-25.
14. Bar-Or, A., L. Fawaz, B. Fan, P. J. Darlington, A. Rieger, C. Ghorayeb, P. A. Calabresi, E. Waubant, S. L. Hauser, J. Zhang, and C. H. Smith. 2010. Abnormal B-cell cytokine responses a trigger of T-cell-mediated disease in MS? Ann. Neurol. 67: 452-461.
15. Serreze, D. V., S. A. Fleming, H. D. Chapman, S. D. Richard, E. H. Leiter, and R. M. Tisch. 1998. B lymphocytes are critical antigen-presenting cells for the initiation of T cell-mediated autoimmune diabetes in nonobese diabetic mice. J. Immunol. 161: 3912-3918. (Pubitemid 28468965)
16. Yan, J., B. P. Harvey, R. J. Gee, M. J. Shlomchik, and M. J. Mamula. 2006. B cells drive early T cell autoimmunity in vivo prior to dendritic cell-mediated autoantigen presentation. J. Immunol. 177: 4481-4487. (Pubitemid 44469778)
17. Zhong, X., W. Gao, N. Degauque, C. Bai, Y. Lu, J. Kenny, M. Oukka, T. B. Strom, and T. L. Rothstein. 2007. Reciprocal generation of Th1/Th17 and T (reg) cells by B1 and B2 B cells. Eur. J. Immunol. 37: 2400-2404. (Pubitemid 47423610)
18. Fillatreau, S., C. H. Sweenie, M. J. McGeachy, D. Gray, and S. M. Anderton. 2002. B cells regulate autoimmunity by provision of IL-10. Nat. Immunol. 3: 944-950. (Pubitemid 35154008)
19. Wolf, S. D., B. N. Dittel, F. Hardardottir, and C. A. Janeway, Jr. 1996. Experimental autoimmune encephalomyelitis induction in genetically B cell-deficient mice. J. Exp. Med. 184: 2271-2278. (Pubitemid 27023727)
20. Matsushita, T., M. Fujimoto, M. Hasegawa, K. Komura, K. Takehara, T. F. Tedder, and S. Sato. 2006. Inhibitory role of CD19 in the progression of experimental autoimmune encephalomyelitis by regulating cytokine response. Am. J. Pathol. 168: 812-821. (Pubitemid 43327734)
21. Duddy, M., M. Niino, F. Adatia, S. Hebert, M. Freedman, H. Atkins, H. J. Kim, and A. Bar-Or. 2007. Distinct effector cytokine profiles of memory and naive human B cell subsets and implication in multiple sclerosis. J. Immunol. 178: 6092-6099. (Pubitemid 46717389)
22. Harp, C. T., S. Ireland, L. S. Davis, G. Remington, B. Cassidy, P. D. Cravens, O. Stuve, A. E. Lovett-Racke, T. N. Eagar, B. M. Greenberg, et al.. 2010. Memory B cells from a subset of treatment-naïve relapsing-remitting multiple sclerosis patients elicit CD4(+) T-cell proliferation and IFN-g production in response to myelin basic protein and myelin oligodendrocyte glycoprotein. Eur. J. Immunol. 40: 2942-2956.
23. Zhang, X., J. Jin, X. Peng, V. S. Ramgolam, and S. Markovic-Plese. 2008. Simvastatin inhibits IL-17 secretion by targeting multiple IL-17-regulatory cytokines and by inhibiting the expression of IL-17 transcription factor RORC in CD4+ lymphocytes. J. Immunol. 180: 6988-6996.
24. von Bergwelt-Baildon, M. S., R. H. Vonderheide, B. Maecker, N. Hirano, K. S. Anderson, M. O. Butler, Z. Xia, W. Y. Zeng, K. W. Wucherpfennig, L. M. Nadler, and J. L. Schultze. 2002. Human primary and memory cytotoxic T lymphocyte responses are efficiently induced by means of CD40-activated B cells as antigen-presenting cells: Potential for clinical application. Blood 99: 3319-3325. (Pubitemid 34525313)
25. Tsukimoto, M., T. Homma, Y. Mutou, and S. Kojima. 2009. 0.5 Gy gamma radiation suppresses production of TNF-alpha through up-regulation of MKP-1 in mouse macrophage RAW264.7 cells. Radiat. Res. 171: 219-224.
26. Han, S. K., J. Y. Song, Y. S. Yun, and S. Y. Yi. 2006. Effect of gamma radiation on cytokine expression and cytokine-receptor mediated STAT activation. Int. J. Radiat. Biol. 82: 686-697.
27. Markovic-Plese, S., H. Fukaura, J. Zhang, A. al-Sabbagh, S. Southwood, A. Sette, V. K. Kuchroo, and D. A. Hafler. 1995. T cell recognition of immunodominant and cryptic proteolipid protein epitopes in humans. J. Immunol. 155: 982-992.
28. Qin, H., C. A. Wilson, S. J. Lee, and E. N. Benveniste. 2006. IFN-beta-induced SOCS-1 negatively regulates CD40 gene expression in macrophages and microglia. FASEB J. 20: 985-987.
29. Acosta-Rodriguez, E. V., G. Napolitani, A. Lanzavecchia, and F. Sallusto. 2007. Interleukins 1beta and 6 but not transforming growth factor-beta are essential for the differentiation of interleukin 17-producing human T helper cells. Nat. Immunol. 8: 942-949. (Pubitemid 47300008)
30. Amadi-Obi, A., C. R. Yu, X. Liu, R. M. Mahdi, G. L. Clarke, R. B. Nussenblatt, I. Gery, Y. S. Lee, and C. E. Egwuagu. 2007. TH17 cells contribute to uveitis and scleritis and are expanded by IL-2 and inhibited by IL-27/STAT1. Nat. Med. 13: 711-718. (Pubitemid 46889754)
31. Harris, D. P., L. Haynes, P. C. Sayles, D. K. Duso, S. M. Eaton, N. M. Lepak, L. L. Johnson, S. L. Swain, and F. E. Lund. 2000. Reciprocal regulation of polarized cytokine production by effector B and T cells. Nat. Immunol. 1: 475-482.
32. Liu, Z., C. M. Pelfrey, A. Cotleur, J. C. Lee, and R. A. Rudick. 2001. Immunomodulatory effects of interferon beta-1a in multiple sclerosis. J. Neuroimmunol. 112: 153-162.
33. Huang, Y., J. J. Feld, R. K. Sapp, S. Nanda, J. H. Lin, L. M. Blatt, M. W. Fried, K. Murthy, and T. J. Liang. 2007. Defective hepatic response to interferon and activation of suppressor of cytokine signaling 3 in chronic hepatitis C. Gastroenterology 132: 733-744. (Pubitemid 46274665)
34. Frobøse, H., S. G. Rønn, P. E. Heding, H. Mendoza, P. Cohen, T. Mandrup- Poulsen, and N. Billestrup. 2006. Suppressor of cytokine Signaling-3 inhibits interleukin-1 signaling by targeting the TRAF-6/TAK1 complex. Mol. Endocrinol. 20: 1587-1596. (Pubitemid 43967566)
35. Wong, P. K., P. J. Egan, B. A. Croker, K. O'Donnell, N. A. Sims, S. Drake, H. Kiu, E. J. McManus, W. S. Alexander, A. W. Roberts, and I. P. Wicks. 2006. SOCS-3 negatively regulates innate and adaptive immune mechanisms in acute IL-1-dependent inflammatory arthritis. J. Clin. Invest. 116: 1571-1581.
36. Zhang, X., J. Jin, Y. Tang, D. Speer, D. Sujkowska, and S. Markovic-Plese. 2009. IFN-beta1a inhibits the secretion of Th17-polarizing cytokines in human dendritic cells via TLR7 up-regulation. J. Immunol. 182: 3928-3936.
37. Li, Y., N. Chu, A. Rostami, and G. X. Zhang. 2006. Dendritic cells transduced with SOCS-3 exhibit a tolerogenic/DC2 phenotype that directs type 2 Th cell differentiation in vitro and in vivo. J. Immunol. 177: 1679-1688. (Pubitemid 44092504)
38. Yang, Z. Z., A. J. Novak, S. C. Ziesmer, T. E. Witzig, and S. M. Ansell. 2009. Malignant B cells skew the balance of regulatory T cells and TH17 cells in Bcell non-Hodgkin's lymphoma. Cancer Res. 69: 5522-5530.
39. Mizoguchi, A., E. Mizoguchi, H. Takedatsu, R. S. Blumberg, and A. K. Bhan. 2002. Chronic intestinal inflammatory condition generates IL-10-producing regulatory B cell subset characterized by CD1d upregulation. Immunity 16: 219-230. (Pubitemid 34211962)